Complex and alternate consent pathways in clinical trials: methodological and ethical challenges encountered by underserved groups and a call to action
ConclusionCollaboration across disciplines, sectors, organisations, and countries is essential if the ethical and methodological challenges surrounding trials involving complex and alternate consent pathways are to be addressed. Explicating these challenges, sharing resources, and identifying gaps for future research is an essential first step. We hope that doing so will serve as a call to action for others seeking ways to address the current consent-based exclusion of underserved populations from trials. (Source: Trials)
Source: Trials - February 28, 2023 Category: Research Source Type: clinical trials

Biological Characteristics of Older Women ( > 70 Years) With ER Positive, HER2 Negative Early Breast Cancer
Condition:   Breast Cancer Female Intervention:   Other: Translational study Sponsors:   Royal Marsden NHS Foundation Trust;   Institute of Cancer Research, United Kingdom;   National Institute for Health Research, United Kingdom Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials